← Leaderboards
Karl A Drlica
Public Health Research Institute
$9,207,096
Attributed
$10,228,821
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$10,228,821 · 4
By mechanism
R01$9,445,540 · 2
R21$783,281 · 2
Top collaborators
- Robert John Kerns5 shared
- Xilin Zhao5 shared
Others in their field
Top investigators on “Dna Gyrase”
- Neil Osheroff · Vanderbilt University$7,793,073
- David C Hooper · Massachusetts Eye And Ear Infirmary$5,699,841
- Zev Bryant · Stanford University$5,142,133
- Christopher T Walsh · Dana-Farber Cancer Institute$4,495,467
- Kenneth J Marians · Sloan-Kettering Institute For Cancer Res$3,808,327
- Lucia B. B Rothman-Denes · University Of Chicago$3,383,050
Research focus
Dna GyraseMycobacterium TuberculosisMutantPharmaceutical PreparationsComplexProteinsStructureKillingsProtein BiosynthesisProgramsBacteriaResistanceInhibitor/AntagonistCell DeathEscherichia ColiLeadInfectionPropertyMediatingTuberculosisFluoroquinolonesCellsQuinolone ResistanceDose
Grant awards (24)
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$385,234
R01 · FY2015 · AI · contact PI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$385,234
R01 · FY2014 · AI · contact PI
Synthetic lethality of bicyclomycin$198,750
R21 · FY2014 · AI · contact PI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$362,120
R01 · FY2013 · AI · contact PI
Synthetic lethality of bicyclomycin$213,160
R21 · FY2013 · AI · contact PI
Synthetic lethality of bicyclomycin$24,965
R21 · FY2013 · AI · contact PI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$326,758
R01 · FY2012 · AI · contact PI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis$73,242
R01 · FY2012 · AI · contact PI
Lethal action of fluoroquinolones with non-growing Mycobacterium tuberculosis$718,233
R01 · FY2011 · AI · contact PI
Lethal action of fluoroquinolones with non-growing Mycobacterium tuberculosis$726,380
R01 · FY2010 · AI · contact PI
Lethal action of fluoroquinolones with non-growing Mycobacterium tuberculosis$714,920
R01 · FY2009 · AI · contact PI
Lethal action of fluoroquinolones with non-growing Mycobacterium tuberculosis$696,668
R01 · FY2008 · AI · contact PI
Lethal action of fluoroquinolones with non-growing Mycobacterium tuberculosis$711,506
R01 · FY2007 · AI · contact PI
DNA gyrase and quinolone resistance in tuberculosis$644,089
R01 · FY2007 · AI · contact PI
DNA gyrase and quinolone resistance in tuberculosis$644,419
R01 · FY2006 · AI · contact PI
Quinolone Action During Mycobacterial Growth Arrest$93,318
R21 · FY2006 · AI · contact PI
Quinolone Action During Mycobacterial Growth Arrest$58,588
R21 · FY2006 · AI · contact PI
DNA gyrase and quinolone resistance in tuberculosis$640,706
R01 · FY2005 · AI
Quinolone Action During Mycobacterial Growth Arrest$194,500
R21 · FY2005 · AI
DNA gyrase and quinolone resistance in tuberculosis$544,245
R01 · FY2004 · AI
DNA gyrase and quinolone resistance in tuberculosis$217,323
R01 · FY2003 · AI
DNA GYRASE AND QUINOLONE RESISTANCE IN TUBERCULOSIS$560,178
R01 · FY2002 · AI
DNA GYRASE AND QUINOLONE RESISTANCE IN TUBERCULOSIS$551,403
R01 · FY2001 · AI
DNA GYRASE AND QUINOLONE RESISTANCE IN TUBERCULOSIS$542,882
R01 · FY2000 · AI